Bacteriophage – A Promising Alternative Measure for Bacterial Biofilm Control

References

• Del Pozo JL. Biofilm-related disease. Expert Rev Anti Infect Ther. 2018;16(1):51–65. doi:10.1080/14787210.2018.141703629235402
   PubMed Web of Science ®Google Scholar
• Racenis K, Kroica J, Rezevska D, et al. S. aureus colonization, biofilm production, and phage susceptibility in peritoneal dialysis patients. Antibiotics. 2020;9:9. doi:10.3390/antibiotics9090582
   Web of Science ®Google Scholar
• Preda VG, Săndulescu O. Communication is the key: biofilms, quorum sensing, formation and prevention. Discoveries. 2019;7(3):e100. doi:10.15190/d.2019.1332309618
   PubMedGoogle Scholar
• Di Domenico EG, Farulla I, Prignano G, et al. Biofilm is a major virulence determinant in bacterial colonization of chronic skin ulcers independently from the multidrug resistant phenotype. Int J Mol Sci. 2017;18:5. doi:10.3390/ijms18051077
   Web of Science ®Google Scholar
• Del Pozo JL, Patel R. Are antibiotics and surgery sufficient to treat biofilm-associated infections? Enferm Infecc Microbiol Clin. 2013;31(10):641–642.24200034
   PubMed Web of Science ®Google Scholar
• Nazir A, Zhao Y, Li M, et al. Structural Genomics of repA, repB1-Carrying IncFIB Family pA1705-qnrS, P911021-tetA, and P1642-tetA, multidrug-resistant plasmids from klebsiella pneumoniae. Infection and Drug Resistance. 2020;13:1889. doi:10.2147/IDR.S22870432606838
   PubMed Web of Science ®Google Scholar
• Moye ZD, Woolston J, Sulakvelidze A. Bacteriophage applications for food production and processing. Viruses. 2018;10:4. doi:10.3390/v10040205
   Web of Science ®Google Scholar
• Schooley RT, Biswas B, Gill JJ, et al. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant acinetobacter baumannii infection. Antimicrob Agents Chemother. 2017;61:10. doi:10.1128/AAC.00954-17
   Web of Science ®Google Scholar
• Philipson CW, Voegtly LJ, Lueder MR, et al. Characterizing phage genomes for therapeutic applications. Viruses. 2018;10:4.
   Web of Science ®Google Scholar
• Donlan RM. Biofilms: microbial life on surfaces. Emerg Infect Dis. 2002;8(9):881–890. doi:10.3201/eid0809.02006312194761
   PubMed Web of Science ®Google Scholar
• Costerton JW, Geesey GG, Cheng KJ. How bacteria stick. Scientific American. 1978;238(1):86–95.635520
   PubMed Web of Science ®Google Scholar
• Fulaz S, Vitale S, Quinn L, Casey E. Nanoparticle-biofilm interactions: the role of the EPS matrix. Trends Microbiol. 2019;27(11):915–926. doi:10.1016/j.tim.2019.07.00431420126
   PubMed Web of Science ®Google Scholar
• Sharma D, Misba L, Khan AU. Antibiotics versus biofilm: an emerging battleground in microbial communities. Antimicrob Resist Infect Control. 2019;8:76. doi:10.1186/s13756-019-0533-331131107
   PubMed Web of Science ®Google Scholar
• Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284(5418):1318–1322. doi:10.1126/science.284.5418.131810334980
   PubMed Web of Science ®Google Scholar
• Donlan RM. Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol. 2009;17(2):66–72. doi:10.1016/j.tim.2008.11.00219162482
   PubMed Web of Science ®Google Scholar
• Halan B, Buehler K, Schmid A. Biofilms as living catalysts in continuous chemical syntheses. Trends Biotechnol. 2012;30(9):453–465. doi:10.1016/j.tibtech.2012.05.00322704028
   PubMed Web of Science ®Google Scholar
• Flemming H-C, Wingender J. The biofilm matrix. Nat Rev Microbiol. 2010;8(9):623–633. doi:10.1038/nrmicro241520676145
   PubMed Web of Science ®Google Scholar
• Mah TFC, O’Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 2001;9(1):34–39. doi:10.1016/S0966-842X(00)01913-211166241
   PubMed Web of Science ®Google Scholar
• Rabin N, Zheng Y, Opoku-Temeng C, Du Y, Bonsu E, Sintim HO. Biofilm formation mechanisms and targets for developing antibiofilm agents. Future Med Chem. 2015;7(4):493–512. doi:10.4155/fmc.15.625875875
   PubMed Web of Science ®Google Scholar
• Kaplan JB. Biofilm dispersal: mechanisms, clinical implications, and potential therapeutic uses. J Dent Res. 2010;89(3):205–218. doi:10.1177/002203450935940320139339
   PubMed Web of Science ®Google Scholar
• Muhammad MH, Idris AL, Fan X, et al. Beyond risk: bacterial biofilms and their regulating approaches. Front Microbiol. 2020;11:928.32508772
   PubMed Web of Science ®Google Scholar
• Renner LD, Weibel DB. Physicochemical regulation of biofilm formation. MRS Bull. 2011;36(5):347–355. doi:10.1557/mrs.2011.6522125358
   PubMed Web of Science ®Google Scholar
• Palmer J, Flint S, Brooks J. Bacterial cell attachment, the beginning of a biofilm. J Ind Microbiol Biotechnol. 2007;34(9):577–588. doi:10.1007/s10295-007-0234-417619090
   PubMed Web of Science ®Google Scholar
• Moormeier DE, Bayles KW. Staphylococcus aureus biofilm: a complex developmental organism. Mol Microbiol. 2017;104(3):365–376. doi:10.1111/mmi.1363428142193
   PubMed Web of Science ®Google Scholar
• Toyofuku M, Inaba T, Kiyokawa T, Obana N, Yawata Y, Nomura N. Environmental factors that shape biofilm formation. Biosci Biotechnol Biochem. 2016;80(1):7–12. doi:10.1080/09168451.2015.105870126103134
   PubMed Web of Science ®Google Scholar
• Tolker-Nielsen T. Biofilm development. Microbiol Spectr. 2015;3(2):Mb-0001-2014. doi:10.1128/microbiolspec.MB-0001-2014
   Google Scholar
• Graves DT, Corrêa JD, Silva TA. The oral microbiota is modified by systemic diseases. J Dent Res. 2019;98(2):148–156. doi:10.1177/002203451880573930359170
   PubMed Web of Science ®Google Scholar
• Marsh PD. Dental plaque as a microbial biofilm. Caries Research. 2004;38(3):204–211. doi:10.1159/00007775615153690
   PubMed Web of Science ®Google Scholar
• Lappin-Scott HM, Bass C. Biofilm formation: attachment, growth, and detachment of microbes from surfaces. Am J Infect Control. 2001;29(4):250–251. doi:10.1067/mic.2001.11567411486266
   PubMed Web of Science ®Google Scholar
• Wilson S, Hamilton MA, Hamilton GC, Schumann MR, Stoodley P. Statistical quantification of detachment rates and size distributions of cell clumps from wild-type (PAO1) and cell signaling mutant (JP1) Pseudomonas aeruginosa biofilms. Appl Environ Microbiol. 2004;70(10):5847–5852. doi:10.1128/AEM.70.10.5847-5852.200415466523
   PubMed Web of Science ®Google Scholar
• Purevdorj-Gage B, Costerton WJ, Stoodley P. Phenotypic differentiation and seeding dispersal in non-mucoid and mucoid Pseudomonas aeruginosa biofilms. Microbiology. 2005;151((Pt5)):1569–1576. doi:10.1099/mic.0.27536-015870466
   PubMed Web of Science ®Google Scholar
• McDougald D, Rice SA, Barraud N, Steinberg PD, Kjelleberg S. Should we stay or should we go: mechanisms and ecological consequences for biofilm dispersal. Nat Rev Microbiol. 2011;10(1):39–50. doi:10.1038/nrmicro269522120588
   PubMed Web of Science ®Google Scholar
• Characklis WG, Marshall KCNYW. Biofilm processes. In Biofilms. 1990;pp195–231.
   Google Scholar
• Lebeaux D, Ghigo JM, Beloin C. Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev. 2014;78(3):510–543.25184564
   PubMed Web of Science ®Google Scholar
• Hughes G, Webber MA. Novel approaches to the treatment of bacterial biofilm infections. Br J Pharmacol. 2017;174(14):2237–2246. doi:10.1111/bph.1370628063237
   PubMed Web of Science ®Google Scholar
• Al-Wrafy F, Brzozowska E, Gorska S, Gamian A. Pathogenic factors of Pseudomonas aeruginosa - the role of biofilm in pathogenicity and as a target for phage therapy. Postepy Hig Med Dosw. 2017;71:78–91. doi:10.5604/01.3001.0010.3792
   Web of Science ®Google Scholar
• Yan Z, Huang M, Melander C, Kjellerup BV. Dispersal and inhibition of biofilms associated with infections. J Appl Microbiol. 2019;128:1279–1288. doi:10.1111/jam.1449131618796
   PubMed Web of Science ®Google Scholar
• Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol. 1999;37(6):1771–1776. doi:10.1128/JCM.37.6.1771-1776.199910325322
   PubMed Web of Science ®Google Scholar
• Fauvart M, De Grootet VN, Michiels J. Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. J Med Microbiol. 2011;60(6):699–709. doi:10.1099/jmm.0.030932-021459912
   PubMed Web of Science ®Google Scholar
• Roy R, Tiwari M, Donelli G, Tiwari V. Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action. Virulence. 2018;9(1):522–554. doi:10.1080/21505594.2017.131337228362216
   PubMed Web of Science ®Google Scholar
• Mathieu J, Yu P, Zuo P, Da Silva MLB, Alvarez PJJ. Going viral: emerging opportunities for phage-based bacterial control in water treatment and reuse. Acc Chem Res. 2019;52(4):849–857. doi:10.1021/acs.accounts.8b0057630925037
   PubMed Web of Science ®Google Scholar
• Sanchez-Vizuete P, Le Coq D, Bridier A, Herry J-M, Aymerich S, Briandet R. Identification of ypqP as a new bacillus subtilis biofilm determinant that mediates the protection of staphylococcus aureus against antimicrobial agents in mixed-species communities. Appl Environ Microbiol. 2015;81(1):109–118. doi:10.1128/AEM.02473-1425326298
   PubMed Web of Science ®Google Scholar
• Labrie SJ, Samson JE, Moineau S. Bacteriophage resistance mechanisms. Nat Rev Microbiol. 2010;8(5):317–327. doi:10.1038/nrmicro231520348932
   PubMed Web of Science ®Google Scholar
• Clokie MR, Millard AD, Letarov AV, Heaphy S. Phages in nature. Bacteriophage. 2011;1(1):31–45. doi:10.4161/bact.1.1.1494221687533
   PubMedGoogle Scholar
• Cisek AA, Dabrowska I, Gregorczyk KP, Wyzewski Z. Phage therapy in bacterial infections treatment: one hundred years after the discovery of bacteriophages. Current Microbiology. 2017;74(2):277–283. doi:10.1007/s00284-016-1166-x27896482
   PubMed Web of Science ®Google Scholar
• Lin DM, Koskella B, Lin HC. Phage therapy: an alternative to antibiotics in the age of multi-drug resistance. World J Gastrointestinal Pharmacol Therapeutics. 2017;8(3):162–173. doi:10.4292/wjgpt.v8.i3.162
   PubMedGoogle Scholar
• Nobrega FL, Vlot M, de Jonge PA, et al. Targeting mechanisms of tailed bacteriophages. Nat Rev Microbiol. 2018;16(12):760–773. doi:10.1038/s41579-018-0070-830104690
   PubMed Web of Science ®Google Scholar
• Azam AH, Tanji Y. Bacteriophage-host arm race: an update on the mechanism of phage resistance in bacteria and revenge of the phage with the perspective for phage therapy. Appl Microbiol Biotechnol. 2019;103(5):2121–2131.30680434
   PubMed Web of Science ®Google Scholar
• Fan X, Li W, Zheng F, Xie J. Bacteriophage inspired antibiotics discovery against infection involved biofilm. Critical Reviews Eukaryotic Gene Expression. 2013;23(4):317–326. doi:10.1615/CritRevEukaryotGeneExpr.2013007717
   Web of Science ®Google Scholar
• Ojha A, Anand M, Bhatt A, Kremer L, Jacobs WR, Hatfull GF. GroEL1: A dedicated chaperone involved in mycolic acid biosynthesis during biofilm formation in mycobacteria. Cell. 2005;123(5):861–873. doi:10.1016/j.cell.2005.09.01216325580
   PubMed Web of Science ®Google Scholar
• Karatan E, Watnick P. Signals, regulatory networks, and materials that build and break bacterial biofilms. Microbiol Mol Biol Rev. 2009;73(2):310–+. doi:10.1128/MMBR.00041-08
   Web of Science ®Google Scholar
• Bruessow H. Bacteriophage-host interaction: from splendid isolation into a messy reality. Curr Opin Microbiol. 2013;16(4):500–506. doi:10.1016/j.mib.2013.04.00723725668
   PubMed Web of Science ®Google Scholar
• Lu TK, Collins JJ. Dispersing biofilms with engineered enzymatic bacteriophage. Proc Nat Acad Sci United States America. 2007;104(27):11197–11202. doi:10.1073/pnas.0704624104
   PubMed Web of Science ®Google Scholar
• Pires DP, Oliveira H, Melo LDR, Sillankorva S, Azeredo J. Bacteriophage-encoded depolymerases: their diversity and biotechnological applications. Appl Microbiol Biotechnol. 2016;100(5):2141–2151. doi:10.1007/s00253-015-7247-026767986
   PubMed Web of Science ®Google Scholar
• Hanlon GW, Denyer SP, Olliff CJ, Ibrahim LJ. Reduction in exopolysaccharide viscosity as an aid to bacteriophage penetration through Pseudomonas aeruginosa biofilms. Appl Environ Microbiol. 2001;67(6):2746–2753. doi:10.1128/AEM.67.6.2746-2753.200111375190
   PubMed Web of Science ®Google Scholar
• Pei R, Lamas-Samanamud GR. Inhibition of biofilm formation by T7 bacteriophages producing quorum-quenching enzymes. Appl Environ Microbiol. 2014;80(17):5340–5348. doi:10.1128/AEM.01434-1424951790
   PubMed Web of Science ®Google Scholar
• Commons J, Morley D, Westra ER, van Houte S. CRISPR-Cas immunity leads to a coevolutionary arms race between Streptococcus thermophilus and lytic phage. Philosophical Transactions Royal Society B-Biol Sci. 2019;374:1772.
   Web of Science ®Google Scholar
• Cohen D, Melamed S, Millman A, et al. Cyclic GMP-AMP signalling protects bacteria against viral infection. Nature. 2019;574(7780):691–+. doi:10.1038/s41586-019-1605-5
   Web of Science ®Google Scholar
• Ofir G, Melamed S, Sberro H, et al. DISARM is a widespread bacterial defence system with broad anti-phage activities. Nat Microbiol. 2018;3(1):90–98. doi:10.1038/s41564-017-0051-029085076
   PubMed Web of Science ®Google Scholar
• Molineux IJ. Host-parasite interactions: recent developments in the genetics of abortive phage infections. New Biol. 1991;3(3):230–236.1831658
   PubMedGoogle Scholar
• Chopin MC, Chopin A, Bidnenko E. Phage abortive infection in lactococci: variations on a theme. Curr Opin Microbiol. 2005;8(4):473–479. doi:10.1016/j.mib.2005.06.00615979388
   PubMed Web of Science ®Google Scholar
• Briandet R, Lacroix-Gueu P, Renault M, et al. Fluorescence correlation spectroscopy to study diffusion and reaction of bacteriophages inside biofilms. Appl Environ Microbiol. 2008;74(7):2135–2143. doi:10.1128/AEM.02304-0718245240
   PubMed Web of Science ®Google Scholar
• Vidakovic L, Singh PK, Hartmann R, Nadell CD, Drescher K. Dynamic biofilm architecture confers individual and collective mechanisms of viral protection. Nature Microbiology. 2018;3:1. doi:10.1038/s41564-017-0050-1
   Web of Science ®Google Scholar
• Kim MS, Kim YD, Hong SS, Park K, Ko KS, Myung H. Phage-encoded colanic acid-degrading enzyme permits lytic phage infection of a capsule-forming resistant mutant escherichia coli strain. Appl Environ Microbiol. 2015;81(3):900–909.25416767
   PubMed Web of Science ®Google Scholar
• Milho C, Silva MD, Alves D, et al. Escherichia coli and Salmonella Enteritidis dual-species biofilms: interspecies interactions and antibiofilm efficacy of phages. Sci Rep. 2019;9:9. doi:10.1038/s41598-019-54847-y30626887
   PubMed Web of Science ®Google Scholar
• Tan D, Zhang Y, Cheng M, et al. Characterization of Klebsiella pneumoniae ST11 isolates and their interactions with lytic phages. Viruses-Basel. 2019;11:11.
   Web of Science ®Google Scholar
• Testa S, Berger S, Piccardi P, Oechslin F, Resch G, Mitri S. Spatial structure affects phage efficacy in infecting dual-strain biofilms of Pseudomonas aeruginosa. Communications Biol. 2019;2. doi:10.1038/s42003-019-0633-x
   Web of Science ®Google Scholar
• Secor PR, Sweere JM, Michaels LA, et al. Filamentous bacteriophage promote biofilm assembly and function. Cell Host Microbe. 2015;18(5):549–559. doi:10.1016/j.chom.2015.10.01326567508
   PubMed Web of Science ®Google Scholar
• Lee Y, Song S, Sheng L, Zhu L, Kim J-S, Wood TK. Substrate binding protein DppA1 of ABC transporter DppBCDF increases biofilm formation in pseudomonas aeruginosa by inhibiting pf5 prophage lysis. Front Microbiol. 2018;24:9.
   Google Scholar
• Rice SA, Tan CH, Mikkelsen PJ, et al. The biofilm life cycle and virulence of Pseudomonas aeruginosa are dependent on a filamentous prophage. Isme Journal. 2009;3(3):271–282. doi:10.1038/ismej.2008.109
   PubMed Web of Science ®Google Scholar
• Davies EV, James CE, Williams D, et al. Temperate phages both mediate and drive adaptive evolution in pathogen biofilms. Proc Nat Acad Sci United States America. 2016;113(29):8266–8271. doi:10.1073/pnas.1520056113
   Web of Science ®Google Scholar
• Bull JJ, Christensen KA, Scott C, Jack BR, Crandall CJ, Krone SM. Phage-bacterial dynamics with spatial structure: self organization around phage sinks can promote increased cell densities. Antibiotics-Basel. 2018;7:1.
   Web of Science ®Google Scholar
• Tan D, Dahl A, Middelboe M. Vibriophages differentially influence biofilm formation by vibrio anguillarum strains. Appl Environ Microbiol. 2015;81(13):4489–4497. doi:10.1128/AEM.00518-1525911474
   PubMed Web of Science ®Google Scholar
• Dancer SJ. The effect of antibiotics on methicillin-resistant Staphylococcus aureus. J Antimicrobial Chemother. 2008;61(2):246–253. doi:10.1093/jac/dkm465
   PubMed Web of Science ®Google Scholar
• Cepas V, López Y, Muñoz E, et al. Relationship between biofilm formation and antimicrobial resistance in gram-negative bacteria. Microb Drug Resist. 2019;25(1):72–79. doi:10.1089/mdr.2018.002730142035
   PubMed Web of Science ®Google Scholar
• Pires DP, Melo LDR, Boas DV, Sillankorva S, Azeredo J. Phage therapy as an alternative or complementary strategy to prevent and control biofilm-related infections. Curr Opin Microbiol. 2017;39:48–56. doi:10.1016/j.mib.2017.09.00428964986
   PubMed Web of Science ®Google Scholar
• Moulton-Brown CE, Friman V-P. Rapid evolution of generalized resistance mechanisms can constrain the efficacy of phage-antibiotic treatments. Evolutionary Applications. 2018;11(9):1630–1641. doi:10.1111/eva.1265330344632
   PubMed Web of Science ®Google Scholar
• Ormälä A-M, Jalasvuori M. Phage therapy: should bacterial resistance to phages be a concern, even in the long run? Bacteriophage. 2013;3(1):e24219–e24219. doi:10.4161/bact.2421923819105
   PubMedGoogle Scholar
• Cesta N, Di Luca M, Corbellino M, Tavio M, Galli M, Andreoni M. Bacteriophage therapy: an overview and the position of italian society of infectious and tropical diseases. Infez Med. 2020;28(3):322–331.32920567
   PubMedGoogle Scholar
• Nzakizwanayo J, Hanin A, Alves DR, et al. Bacteriophage can prevent encrustation and blockage of urinary catheters by proteus mirabilis. Antimicrob Agents Chemother. 2016;60(3):1530–1536. doi:10.1128/AAC.02685-15
   Web of Science ®Google Scholar
• Cano EJ, Caflisch KM, Bollyky PL, et al. Phage therapy for limb-threatening prosthetic knee klebsiella pneumoniae infection: case report and in vitro characterization of anti-biofilm activity. Clin Infect Dis. 2020. doi:10.1093/cid/ciaa705
   Web of Science ®Google Scholar
• Shlezinger M, Khalifa L, Houri-Haddad Y, et al. Phage therapy: a new horizon in the antibacterial treatment of oral pathogens. Curr Top Med Chem. 2017;17(10):1199–1211. doi:10.2174/156802661666616093014564927770768
   PubMed Web of Science ®Google Scholar
• Shlezinger M, Friedman M, Houri-Haddad Y, Hazan R, Beyth N. Phages in a thermoreversible sustained-release formulation targeting E. faecalis in vitro and in vivo. PLoS One. 2019;14(7):e0219599. doi:10.1371/journal.pone.021959931291645
   PubMed Web of Science ®Google Scholar
• Khalifa L, Brosh Y, Gelman D, et al. Targeting Enterococcus faecalis biofilms with phage therapy. Appl Environ Microbiol. 2015;81(8):2696–2705. doi:10.1128/AEM.00096-1525662974
   PubMed Web of Science ®Google Scholar
• Selezska K, Kazmierczak M, Muesken M, et al. Pseudomonas aeruginosa population structure revisited under environmental focus: impact of water quality and phage pressure. Environ Microbiol. 2012;14(8):1952–1967.22390474
   PubMed Web of Science ®Google Scholar
• Alves DR, Perez-Esteban P, Kot W, et al. A novel bacteriophage cocktail reduces and disperses Pseudomonas aeruginosa biofilms under static and flow conditions. Microb Biotechnol. 2016;9(1):61–74.26347362
   PubMed Web of Science ®Google Scholar
• Burrows LL. The therapeutic pipeline for pseudomonas aeruginosa Infections. ACS Infectious Diseases. 2018;4(7):1041–1047.29771109
   PubMed Web of Science ®Google Scholar
• Fong SA, Drilling AJ, Ooi ML, et al. Safety and efficacy of a bacteriophage cocktail in an in vivo model of Pseudomonas aeruginosa sinusitis. Translational Res. 2019;206:41–56.
   PubMed Web of Science ®Google Scholar
• Alemayehu D, Casey PG, McAuliffe O, et al. Bacteriophages phi MR299-2 and phi NH-4 can eliminate pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. Mbio. 2012;3:2.
   Web of Science ®Google Scholar
• Coulter LB, McLean RJC, Rohde RE, Aron GM. Effect of bacteriophage infection in combination with tobramycin on the emergence of resistance in escherichia coli and pseudomonas aeruginosa biofilms. Viruses-Basel. 2014;6(10):3778–3786.
   Web of Science ®Google Scholar
• Kumaran D, Taha M, Yi Q, et al. Does treatment order matter? investigating the ability of bacteriophage to augment antibiotic activity against staphylococcus aureus biofilms. Front Microbiol. 2018;9:127.29459853
   PubMed Web of Science ®Google Scholar
• Shlezinger M, Coppenhagen-Glazer S, Gelman D, Beyth N, Hazan R. Eradication of vancomycin-resistant enterococci by combining phage and vancomycin. Viruses-Basel. 2019;11:10.
   Web of Science ®Google Scholar
• Lu TK, Collins JJ. Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. Proc Nat Acad Sci United States America. 2009;106(12):4629–4634.
   PubMed Web of Science ®Google Scholar
• Srinivasan R, Chaitanyakumar A, Subramanian P, et al. Recombinant engineered phage-derived enzybiotic in Pichia pastoris X-33 as whole cell biocatalyst for effective biocontrol of Vibrio parahaemolyticus in aquaculture. International J Biol Macromolecules. 2019.
   Web of Science ®Google Scholar
• Yilmaz C, Colak M, Yilmaz BC, Ersoz G, Kutateladze M, Gozlugol M. Bacteriophage therapy in implant-related infections an experimental study. J Bone Joint Surgery-Am. 2013;95A(2):117–125.
   Web of Science ®Google Scholar
• Chang RYK, Das T, Manos J, Kutter E, Morales S, Chan HK. Bacteriophage PEV20 and ciprofloxacin combination treatment enhances removal of pseudomonas aeruginosa biofilm isolated from cystic fibrosis and wound patients. AAPS J. 2019;21(3):49.30949776
   PubMed Web of Science ®Google Scholar
• Lin Y, Chang RYK, Britton WJ, Morales S, Kutter E, Chan HK. Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa. Int J Pharm. 2018;551(1–2):158–165.30223075
   PubMed Web of Science ®Google Scholar
• Abedon ST. Phage-antibiotic combination treatments: antagonistic impacts of antibiotics on the pharmacodynamics of phage therapy? Antibiotics. 2019;8(4):182.
   Web of Science ®Google Scholar
• Casey E, van Sinderen D, Mahony J. In vitro characteristics of phages to guide ‘real life’ phage therapy suitability. Viruses. 2018;10:4.
   Web of Science ®Google Scholar
• Tagliaferri TL, Jansen M, Horz HP. Fighting pathogenic bacteria on two fronts: phages and antibiotics as combined strategy. Front Cell Infect Microbiol. 2019;9:22. doi:10.3389/fcimb.2019.0002230834237
   PubMed Web of Science ®Google Scholar
• Latz S, Kruettgen A, Haefner H, Buhl EM, Ritter K, Horz H-P. Differential effect of newly isolated phages belonging to PB1-Like, phiKZ-Like and LUZ24-like viruses against multi-drug resistant pseudomonas aeruginosa under varying growth conditions. Viruses-Basel. 2017;9:11.
   Web of Science ®Google Scholar
• Forti F, Roach DR, Cafora M, et al. Design of a broad-range bacteriophage cocktail that reduces pseudomonas aeruginosa biofilms and treats acute infections in two animal models. Antimicrob Agents Chemother. 2018;62:6. doi:10.1128/AAC.02573-17
   Web of Science ®Google Scholar
• Alves DR, Gaudion A, Bean JE, et al. Combined use of bacteriophage k and a novel bacteriophage to reduce staphylococcus aureus biofilm formation. Appl Environ Microbiol. 2014;80(21):6694–6703. doi:10.1128/AEM.01789-1425149517
   PubMed Web of Science ®Google Scholar
• Schuch R, Khan BK, Raz A, Rotolo JA, Wittekind M. Bacteriophage lysin CF-301, a potent antistaphylococcal biofilm agent. Antimicrob Agents Chemother. 2017;61:7.
   Web of Science ®Google Scholar
• Paul VD, Rajagopalan SS, Sundarrajan S, et al. A novel bacteriophage Tail-Associated Muralytic Enzyme (TAME) from Phage K and its development into a potent antistaphylococcal protein. Bmc Microbiology. 2011;11.21241461
   PubMed Web of Science ®Google Scholar
• Poonacha N, Nair S, Desai S, et al. Efficient killing of planktonic and biofilm-embedded coagulase-negative staphylococci by bactericidal protein P128. Antimicrob Agents Chemother. 2017;61:8. doi:10.1128/AAC.00457-17
   Web of Science ®Google Scholar
• Channabasappa S, Durgaiah M, Chikkamadaiah R, Kumar S, Joshi A, Sriram B. Efficacy of novel antistaphylococcal ectolysin P128 in a rat model of methicillin-resistant staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2018;62:2.
   Web of Science ®Google Scholar
• Diez-Martinez R, De Paz HD, Garcia-Fernandez E, et al. A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae. J Antimicrobial Chemother. 2015;70(6):1763–1773.
   PubMed Web of Science ®Google Scholar
• Meng X, Shi Y, Ji W, et al. Application of a bacteriophage lysin to disrupt biofilms formed by the animal pathogen streptococcus suis. Appl Environ Microbiol. 2011;77(23):8272–8279. doi:10.1128/AEM.05151-1121984241
   PubMed Web of Science ®Google Scholar
• Rios AC, Moutinho CG, Pinto FC, et al. Alternatives to overcoming bacterial resistances: state-of-the-art. Microbiological Research. 2016;2016(191):51–80. doi:10.1016/j.micres.2016.04.008
   Web of Science ®Google Scholar
• Lood R, Winer BY, Pelzek AJ, et al. Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium acinetobacter baumannii in a mouse bacteremia model. Antimicrob Agents Chemother. 2015;59(4):1983–1991. doi:10.1128/AAC.04641-1425605353
   PubMed Web of Science ®Google Scholar
• Thandar M, Lood R, Winer BY, Deutsch DR, Euler CW, Fischetti VA. Novel engineered peptides of a phage lysin as effective antimicrobials against multidrug-resistant acinetobacter baumannii. Antimicrob Agents Chemother. 2016;60(5):2671–2679. doi:10.1128/AAC.02972-1526856847
   PubMed Web of Science ®Google Scholar
• Yang H, Bi Y, Shang X, et al. Antibiofilm activities of a novel chimeolysin against streptococcus mutans under physiological and cariogenic conditions. Antimicrob Agents Chemother. 2016;60(12):7436–7443.27736755
   PubMed Web of Science ®Google Scholar
• Vazquez R, Garcia P. Synergy between two chimeric lysins to kill streptococcus pneumoniae. Front Microbiol. 2019;10:10. doi:10.3389/fmicb.2019.0125130728810
   PubMed Web of Science ®Google Scholar
• Muziasari WI, Pitkanen LK, Sorum H, Stedtfeld RD, Tiedje JM, Virta M. The resistome of farmed fish feces contributes to the enrichment of antibiotic resistance genes in sediments below baltic sea fish farms. Front Microbiol. 2017;7.
   Google Scholar
• Wang J, Liu Q, Wu B, et al. Quorum sensing signaling distribution during the development of full-scale municipal wastewater treatment biofilms. Sci Total Environ. 2019;685:28–36. doi:10.1016/j.scitotenv.2019.05.24931174122
   PubMed Web of Science ®Google Scholar
• Zhang Y, Hu Z. Combined treatment of Pseudomonas aeruginosa biofilms with bacteriophages and chlorine. Biotechnol Bioengineering. 2013;110(1):286–295. doi:10.1002/bit.24630
   Web of Science ®Google Scholar
• Goldman G, Starosvetsky J, Armon R. Inhibition of biofilm formation on UF membrane by use of specific bacteriophages. J Membrane Sci. 2009;342(1–2):145–152. doi:10.1016/j.memsci.2009.06.036
   Web of Science ®Google Scholar
• Cabello FC, Godfrey HP, Tomova A, et al. Antimicrobial use in aquaculture re-examined: its relevance to antimicrobial resistance and to animal and human health. Environ Microbiol. 2013;15(7):1917–1942.23711078
   PubMed Web of Science ®Google Scholar
• Tomova A, Ivanova L, Buschmann AH, et al. Antimicrobial resistance genes in marine bacteria and human uropathogenic Escherichia coli from a region of intensive aquaculture. Environmental Microbiology Reports. 2015;7(5):803–809. doi:10.1111/1758-2229.1232726259681
   PubMed Web of Science ®Google Scholar
• Maje MD, Kaptchouang Tchatchouang CD, Manganyi MC, Fri J, Ateba CN. Characterisation of vibrio species from surface and drinking water sources and assessment of biocontrol potentials of their bacteriophages. Int J Microbiol. 2020;2020:8863370. doi:10.1155/2020/886337032831847
   PubMed Web of Science ®Google Scholar
• Matamp N, Bhat SG. Phage endolysins as potential antimicrobials against multidrug resistant vibrio alginolyticus and vibrio parahaemolyticus: current status of research and challenges ahead. Microorganisms. 2019;7:3. doi:10.3390/microorganisms7030084
   Web of Science ®Google Scholar
• Coughlan LM, Cotter PD, Hill C, Alvarez-Ordonez A. New weapons to fight old enemies: novel strategies for the (bio) control of bacterial biofilms in the food industry. Front Microbiol. 2016;7. doi:10.3389/fmicb.2016.0164126858696
   PubMed Web of Science ®Google Scholar
• Colagiorgi A, Bruini I, Di Ciccio PA, Zanardi E, Ghidini S, Ianieri A. Listeria monocytogenes biofilms in the wonderland of food industry. Pathogens. 2017;6:3. doi:10.3390/pathogens6030041
   Web of Science ®Google Scholar
• Galie S, Garcia-Gutierrez C, Miguelez EM, Villar CJ, Lombo F. Biofilms in the food industry: health aspects and control methods. Front Microbiol. 2018;9:9. doi:10.3389/fmicb.2018.0089829387050
   PubMed Web of Science ®Google Scholar
• Van Houdt R, Michiels CW. Biofilm formation and the food industry, a focus on the bacterial outer surface. J Appl Microbiol. 2010;109(4):1117–1131. doi:10.1111/j.1365-2672.2010.04756.x20522145
   PubMed Web of Science ®Google Scholar
• Gray JA, Chandry PS, Kaur M, Kocharunchitt C, Bowman JP, Fox EM. Novel biocontrol methods for listeria monocytogenes biofilms in food production facilities. Front Microbiol. 2018;9:9. doi:10.3389/fmicb.2018.0060529387050
   PubMed Web of Science ®Google Scholar
• Iacumin L, Manzano M, Comi G. Phage inactivation of listeria monocytogenes on san daniele dry-cured ham and elimination of biofilms from equipment and working environments. Microorganisms. 2016;4:1. doi:10.3390/microorganisms4010004
   Web of Science ®Google Scholar
• Soni KA, Nannapaneni R. Removal of listeria monocytogenes biofilms with bacteriophage P100. J Food Prot. 2010;73(8):1519–1524. doi:10.4315/0362-028X-73.8.151920819365
   PubMed Web of Science ®Google Scholar
• Arachchi GJG, Cridge AG, Dias-Wanigasekera BM, et al. Effectiveness of phages in the decontamination of Listeria monocytogenes adhered to clean stainless steel, stainless steel coated with fish protein, and as a biofilm. J Ind Microbiol Biotechnol. 2013;40(10):1105–1116. doi:10.1007/s10295-013-1313-323907252
   PubMed Web of Science ®Google Scholar
• Gutierrez D, Rodriguez-Rubio L, Martinez B, Rodriguez A, Garcia P. Bacteriophages as weapons against bacterial biofilms in the food industry. Front Microbiol. 2016;7:7. doi:10.3389/fmicb.2016.0082526858696
   PubMed Web of Science ®Google Scholar
• Pires DP, Dötsch A, Anderson EM, et al. A genotypic analysis of five P. aeruginosa strains after biofilm infection by phages targeting different cell surface receptors. Front Microbiol. 2017;8:1229. doi:10.3389/fmicb.2017.0122928713356
   PubMed Web of Science ®Google Scholar
• Sumrall ET, Shen Y, Keller AP, et al. Phage resistance at the cost of virulence: listeria monocytogenes serovar 4b requires galactosylated teichoic acids for InlB-mediated invasion. PLoS Pathogens. 2019;15(10):e1008032. doi:10.1371/journal.ppat.100803231589660
   PubMed Web of Science ®Google Scholar
• Novick RP. Pathogenicity islands and their role in staphylococcal biology. Gram-Positive Pathogens. 2019;536–548.
   Google Scholar
• Koskella B, Brockhurst MA. Bacteria-phage coevolution as a driver of ecological and evolutionary processes in microbial communities. FEMS Microbiol Rev. 2014;38(5):916–931. doi:10.1111/1574-6976.1207224617569
   PubMed Web of Science ®Google Scholar
• Xiong X, Wu G, Wei Y, et al. SspABCD–SspE is a phosphorothioation-sensing bacterial defence system with broad anti-phage activities. Nature Microbiology. 2020;1–12.31740776
   PubMed Web of Science ®Google Scholar
• Stanley SY, Maxwell KL. Phage-encoded anti-CRISPR defenses. Annu Rev Genet. 2018;52:445–464. doi:10.1146/annurev-genet-120417-03132130208287
   PubMed Web of Science ®Google Scholar
• Sharma U, Vipra A, Channabasappa S. Phage-derived lysins as potential agents for eradicating biofilms and persisters. Drug Discov Today. 2018;23(4):848–856. doi:10.1016/j.drudis.2018.01.02629326076
   PubMed Web of Science ®Google Scholar